The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI

NCT01866800 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2019-05-23

No results posted yet for this study

Summary

Evaluating whether forced diuresis with matched hydration will reduce the risk of contrast induced nephropathy in patients undergoing Transcatheter Aortic Valve Implantation (TAVI).

Conditions

  • Radiographic Contrast Agent Nephropathy
  • Aortic Valve Stenosis With Insufficiency

Interventions

DEVICE

Renal Guard

Renal Guard

DRUG

Conventional Treatment

Saline and N-acetylcysteine

Sponsors & Collaborators

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Shmuel Banai, Prof. · Tel Aviv Sourasky MC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-01
Primary Completion
2019-04-01
Completion
2019-05-22

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01866800 on ClinicalTrials.gov